ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026

RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236.

Alexander J Pfeil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.